Bernstein Williams + Co. Research
Advisory Approach
Bernstein Williams + Co. is a specialized healthcare and life sciences investment bank founded by Theodore W. Bernstein, a recognized expert with more than 25 years of M&A, finance, and healthcare executive experience. The firm operates from Stamford, Connecticut and is committed to providing deep industry expertise combined with sophisticated advisory services to healthcare and life sciences clients nationwide. The firm's thesis is that healthcare and life sciences transactions require not just technical M&A proficiency, but genuine operational and clinical understanding of the industries being served. Theodore Bernstein brings a unique combination of academic credentials (JD, MBA, MPH), legal experience (Skadden Arps), institutional investment banking background (Wasserstein Perella), and hands-on operating experience (Massachusetts General Hospital, private equity, and multiple hedge fund roles).
Healthcare & Life Sciences Expertise
Bernstein Williams focuses exclusively on the healthcare and life sciences sectors, where complex regulatory environments, clinical operations, and evolving reimbursement models demand specialized knowledge. Theodore Bernstein's background demonstrates deep expertise across the healthcare ecosystem: he began his operating career as an Administrative Fellow at Massachusetts General Hospital, providing foundational understanding of healthcare operations; subsequently trained as a healthcare attorney at Skadden Arps, where he concentrated on financing healthcare and technology companies through public markets; and later earned #1 research rankings from Institutional Investor for his sell-side healthcare coverage at Wasserstein Perella & Co. He expanded his perspective through hedge fund roles at Avenue Capital Group, where he served as principal and portfolio manager analyzing healthcare investments, and progressed to managing partner of N-Squared Growth Capital, a New York-based private equity firm focused primarily on healthcare services and healthcare-related technology and business services.
Transaction Experience & Process
Bernstein Williams provides comprehensive M&A advisory services across the healthcare and life sciences value chain, including sell-side advisory, buy-side representation, capital raising, and strategic transaction execution. Theodore Bernstein's extensive transaction experience spans sell-side processes, buy-side opportunity origination and due diligence, deal negotiation and execution, regulatory and compliance matters, capital sourcing, and managing complex stakeholder relationships. The firm advises on transactions involving physician practices, healthcare services companies, life sciences platforms, healthcare technology vendors, medical device businesses, diagnostic providers, and various healthcare IT and operations solutions. Due to the highly regulated nature of healthcare M&A, the firm's advisory includes deep expertise in regulatory approvals, state licensing transfers, compliance with Stark Law and Anti-Kickback Statute considerations, and post-deal integration challenges unique to healthcare.
Market Focus & Sweet Spot
Bernstein Williams targets healthcare and life sciences business owners and investors seeking sophisticated M&A advisory in transactions of strategic importance. The firm works with founder-led and family-owned healthcare businesses, management teams seeking growth capital or exit opportunities, private equity firms acquiring healthcare assets, and strategic healthcare buyers (hospital systems, large medical device manufacturers, pharmaceutical companies) pursuing tuck-in or platform acquisitions. The firm is particularly well-positioned for middle-market healthcare transactions where operational complexity, regulatory considerations, and clinical expertise differentiate value creation.
Team & Credentials
Theodore W. Bernstein serves as the principal and founder of Bernstein Williams + Co. LLC. His educational background includes:
- Bachelor of Arts in Natural Sciences from The Johns Hopkins University
- Juris Doctor from University of Chicago Law School
- Master of Business Administration in Finance from Chicago Booth School of Business
- Master of Public Health in Healthcare Management from Yale School of Public Health
This rare combination of clinical science, law, business finance, and public health credentials positions Theodore uniquely to advise on complex healthcare transactions. He has worked with leading financial and strategic buyers in healthcare and maintains active relationships across the healthcare investment and operational landscape.
Positioning & Differentiation
Bernstein Williams differentiates itself through several key dimensions:
Depth of Healthcare Expertise: Unlike generalist advisory firms, every aspect of the firm's practice is focused exclusively on healthcare and life sciences. Theodore Bernstein's background spans operating experience, legal transaction work, institutional sell-side research, buy-side investing, and private equity investing—all within healthcare.
Regulatory & Compliance Knowledge: Healthcare transactions involve complex regulatory requirements. The firm's expertise in healthcare law, compliance structures, and post-deal regulatory integration is a core differentiator.
Institutional Relationships: Theodore Bernstein has built relationships across the healthcare ecosystem through his career at major institutions (Massachusetts General Hospital, Skadden Arps, Wasserstein Perella, hedge funds, private equity), providing access to buyers, capital sources, and market intelligence.
Process Rigor: The firm applies institutional-quality process discipline to middle-market healthcare transactions, providing business owners the same level of advisory sophistication typically available only to much larger enterprises.
Market Position
Bernstein Williams + Co. is positioned as a boutique healthcare investment bank specializing in complex transactions requiring deep industry expertise. The firm is registered as an investment bank and advisor through Britehorn Securities (Theodore Bernstein holds FINRA registrations including Series 79 and Series 63). The firm maintains active involvement in the healthcare M&A ecosystem, as evidenced by membership on Axial (joined 2020), a leading lower-middle-market deal platform, and recognition in investment banking directories.
Approach to Client Engagement
The firm believes that successful healthcare transactions require alignment between buyer and seller motivations, clear understanding of value drivers unique to healthcare businesses, and meticulous attention to operational and regulatory detail. Theodore Bernstein works closely with business owners, management teams, and investors to translate strategic objectives into executable transactions, providing advisory support across pre-transaction planning, buyer identification and outreach, deal negotiation, regulatory approval navigation, and integration planning.